NAICS 541714

Research and Development in Biotechnology (except Nanobiotechnology) contracts

Open federal opportunities classified under NAICS 541714.

What next? Found opportunities you can win? Apply for access to bid with AI.

Apply for access →

Get email alerts for this search

New contracts matching these filters, straight to your inbox. No account needed.

We’ll only email you about matching contracts. Want instant alerts, saved searches and AI proposals? Apply for access →

Set-asides used in this sector

Small Business8(a)HUBZoneSDVOSBWOSB

About NAICS 541714

Biotechnology R&D — recombinant DNA, cell biology, immunology, and related research. Heavily used by NIH, BARDA, and DoD medical research commands for funded biotech programmes.

Typical award value: $500K – $100M+ per award.

New to this market? Read the in-depth guide: How to win NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) federal contracts →

Research and Development in Biotechnology (except Nanobiotechnology) contracts

About NAICS 541714

Research and Development in Biotechnology (except Nanobiotechnology) contracts

About NAICS 541714

Illumina Reagent Kits

Battlefield Pain Management – Analgesic

Development of Light-Responsive Artificial Cells using Plant-Based Photoreceptor Systems

Non-Optical Methods for High Speed Protein Control

Notice of Intent to Sole Source – University of Maryland Medical Center

Hypoxia Chamber Services

Hypobaric Chamber Pilot Studies

Hypoxia Chamber Services

Multiscale Reasoning For Human Physiology RFI

RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

TECHNOLOGY LICENSING OPPORTUNITY: Platform to Accelerate Discovery of Tailored Industrial Enzymes (PAD-TIE)

RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA3

Battlefield Pain Management – Analgesic

TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET

Trusted Partner Program - Questions & Answers

RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter

Non-Optical Methods for High Speed Protein Control

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

NAWCWD Broad Agency Announcement

Biological Technologies

BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)